Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- May 16, 2018 - 1:06pm | Financings
- April 9, 2018 - 9:53am | Research Notes, Financings
- March 26, 2018 - 9:45am | Financings
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- March 4, 2018 - 11:11am | Analysis, Out and About
- November 28, 2017 - 6:26pm | Research Notes, Financings
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- March 10, 2017 - 12:00am | Earnings, Earnings Q4
- January 5, 2017 - 10:16am | Research Notes
- November 2, 2016 - 8:46pm | Earnings, Earnings Q3
- August 25, 2016 - 7:57am | Research Notes
- August 4, 2016 - 10:50pm | Earnings, Earnings Q2
- August 4, 2016 - 9:51am | Research Notes, Financings
- August 3, 2016 - 10:41am | Research Notes
- May 19, 2016 - 10:49am | Research Notes
- May 11, 2016 - 10:57am | Research Notes, Henry'omics
- February 3, 2016 - 9:29am | Research Notes
- November 16, 2015 - 10:34am | Earnings Q3